Last updated: August 23, 2022
Sponsor: Johns Hopkins University
Overall Status: Trial Not Available
Phase
N/A
Condition
Dermatitis, Atopic
Allergy
Eczema (Atopic Dermatitis)
Treatment
N/AClinical Study ID
NCT03843437
IRB00176371
Ages 6-6 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of moderate or severe atopic dermatitis based on Eczema Area and SeverityIndex (EASI) score (moderate=6-22.9; severe=23-72)
- At least one active patch of atopic dermatitis at time of study
- Parent/guardian able to give informed consent
Exclusion
Exclusion Criteria:
- Systemic medication or oral steroids within past 3 months (includes light therapy),
- Started new atopic dermatitis treatment regimen within the past month,
- Using wet/dry wraps > once/week
Study Design
Study Start date:
July 01, 2022
Estimated Completion Date:
June 28, 2024
Study Description
Connect with a study center
Johns Hopkins Pediatric Dermatology Clinic
Baltimore, Maryland 21287
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.